Moving Medicines
to Move People

Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with rare genetic mitochondrial diseases.

Our priority is to meet the needs of patients through the development of targeted drugs for genetic rare diseases.

We believe REN001 could benefit patients with genetic mitochondrial myopathies.

Latest News